Anthony J. Japour

Lopinavir–Ritonavir versus Nelfinavir for the Initial Treatment of HIV Infection

Sharon Walmsley, Barry Bernstein, Martin King et al. · New England Journal of Medicine · 2002 · 650 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

The Relation of Virologic and Immunologic Markers to Clinical Outcomes after Nucleoside Therapy in HIV-Infected Adults with 200 to 500 CD4 Cells per Cubic Millimeter

David Katzenstein, Scott M. Hammer, Michael D. Hughes et al. · New England Journal of Medicine · 1996 · 485 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

ABT-378, a Highly Potent Inhibitor of the Human Immunodeficiency Virus Protease

Hing L. Sham, Dale J. Kempf, Akhteruzammen Molla et al. · Antimicrobial Agents and Chemotherapy · 1998 · 470 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease

Elizabeth Race, Jennifer Adelson-Mitty, Gila Kriegel et al. · The Lancet · 1998 · 361 citations

Veterinary Medicine, Infectious Diseases, Microbiology +16

ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results

Robert L. Murphy, Scott Brun, Charles B. Hicks et al. · AIDS · 2001 · 239 citations

Pharmacy, Pharmacology, Pharmacotherapy +17